Compare $KRMD vs $LUCD | Chartloom

Compare

$KRMD vs $LUCD

KORU Medical Systems Inc · Lucid Diagnostics Inc

KRMD

KORU Medical Systems Inc

LUCD

Lucid Diagnostics Inc

Compare $KRMD vs $LUCD

Comparing KORU Medical Systems Inc and Lucid Diagnostics Inc

KRMDKORU Medical Systems Inc

LUCDLucid Diagnostics Inc

KRMDKORU Medical Systems Inc

Market cap

$136M

P/E (TTM)

—

Forward P/E (NTM)

1,748.17x

Forward P/S (NTM)

2.55x

Rev growth (TTM)

22.4%

YTD performance

-47.2%

52W performance

-29.4%

FCF yield

0.2%

LUCDLucid Diagnostics Inc

Market cap

$122M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

13.06x

Rev growth (TTM)

24.9%

YTD performance

-43.0%

52W performance

-47.7%

FCF yield

-38.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KRMD

LUCD

Detailed metrics comparison

KRMD

KORU Medical Systems Inc

LUCD

Lucid Diagnostics Inc

Market Cap

KRMD$136M

LUCD$122M

Enterprise Value

KRMD$128M

LUCD$112M

Price

KRMD$2.96

LUCD$0.64

P/E Ratio

KRMDN/A

LUCDN/A

P/S Ratio

KRMD3.01x

LUCD22.35x

EV/Sales

KRMD2.84x

LUCD20.53x

EV/EBITDA

KRMD918.58x

LUCD0.00x

P/B Ratio

KRMD7.57x

LUCD11.67x

P/FCF Ratio

KRMD559.48x

LUCDN/A

EV/FCF

KRMD526.28x

LUCD-2.37x

PEG Ratio

KRMDN/A

LUCDN/A

Forward P/E (NTM)

KRMD1,748.17x

LUCDN/A

Forward P/S (NTM)

KRMD2.55x

LUCD13.06x

Revenue (TTM)

KRMD$45M

LUCD$5M

Revenue Growth (YoY)

KRMD22.4%

LUCD24.9%

Forward Rev Growth

KRMD17.2%

LUCD163.5%

Gross Margin (TTM)

KRMD62.4%

LUCD-21.7%

Operating Margin (TTM)

KRMD0.0%

LUCD0.0%

EBITDA Margin (TTM)

KRMD-1.9%

LUCD-914.8%

Net Margin (TTM)

KRMD-4.0%

LUCD-1193.9%

FCF Margin (TTM)

KRMD0.5%

LUCD-866.6%

Net Income (TTM)

KRMD$-2M

LUCD$-65M

FCF (TTM)

KRMD$243K

LUCD$-47M

EPS (TTM)

KRMD-$0.04

LUCD-$0.35

ROE (TTM)

KRMD-1063.0%

LUCD-40434.0%

ROA (TTM)

KRMD-651.0%

LUCD-12542.0%

ROIC (TTM)

KRMD-1045.0%

LUCD-14249.0%

Cash

KRMD$8M

LUCD$33M

Debt

KRMD$220K

LUCD$24M

Net Cash/Debt

KRMD$8M

LUCD$10M

Current Ratio (TTM)

KRMD2.72x

LUCD1.33x

Quick Ratio (TTM)

KRMD2.00x

LUCD1.29x

Debt/Equity (TTM)

KRMD0.01x

LUCD2.15x

Debt/Assets (TTM)

KRMD0.0%

LUCD0.0%

Interest Coverage (TTM)

KRMDN/A

LUCDN/A

Net Debt/EBITDA (TTM)

KRMD0.00x

LUCD0.00x

Beta

KRMD0.52

LUCD1.16

52W Performance

KRMD-29.4%

LUCD-47.7%

YTD Performance

KRMD-47.2%

LUCD-43.0%

% from 52W High

KRMD-55.2%

LUCD-60.8%

% from 52W Low

KRMD3.5%

LUCD27.6%

Asset Turnover (TTM)

KRMD1.61x

LUCD0.13x

FCF Yield (TTM)

KRMD0.2%

LUCD-38.8%

Earnings Yield (TTM)

KRMD-1.3%

LUCD-53.4%

Dividend Yield (TTM)

KRMDN/A

LUCDN/A

Rule of 40

KRMD23.0

LUCD-841.7

EV/GP/RG

KRMD0.25

LUCDN/A

Ticker research

View KRMD research View LUCD research

Metric	KRMD KORU Medical Systems Inc	LUCD Lucid Diagnostics Inc
Market & Valuation
Market Cap	$136M	$122M
Enterprise Value	$128M	$112M
Price	$2.96	$0.64
P/E Ratio	N/A	N/A
P/S Ratio	3.01x	22.35x
EV/Sales	2.84x	20.53x
EV/EBITDA	918.58x	0.00x
P/B Ratio	7.57x	11.67x
P/FCF Ratio	559.48x	N/A
EV/FCF	526.28x	-2.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1,748.17x	N/A
Forward P/S (NTM)	2.55x	13.06x
Revenue & Growth
Revenue (TTM)	$45M	$5M
Revenue Growth (YoY)	22.4%	24.9%
Forward Rev Growth	17.2%	163.5%
Profitability
Gross Margin (TTM)	62.4%	-21.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-914.8%
Net Margin (TTM)	-4.0%	-1193.9%
FCF Margin (TTM)	0.5%	-866.6%
Net Income (TTM)	$-2M	$-65M
FCF (TTM)	$243K	$-47M
EPS (TTM)	-$0.04	-$0.35
ROE (TTM)	-1063.0%	-40434.0%
ROA (TTM)	-651.0%	-12542.0%
ROIC (TTM)	-1045.0%	-14249.0%
Financial Health
Cash	$8M	$33M
Debt	$220K	$24M
Net Cash/Debt	$8M	$10M
Current Ratio (TTM)	2.72x	1.33x
Quick Ratio (TTM)	2.00x	1.29x
Debt/Equity (TTM)	0.01x	2.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.16
52W Performance	-29.4%	-47.7%
YTD Performance	-47.2%	-43.0%
% from 52W High	-55.2%	-60.8%
% from 52W Low	3.5%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	1.61x	0.13x
FCF Yield (TTM)	0.2%	-38.8%
Earnings Yield (TTM)	-1.3%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	23.0	-841.7
EV/GP/RG	0.25	N/A
Ticker research	View KRMD research	View LUCD research

Valuation

P/S Ratio

KRMD

3.01x

LUCD

22.35x

EV/FCF

LUCD

-2.37x

KRMD

526.28x

Growth & revenue

Revenue Growth TTM

LUCD

24.9%

KRMD

22.4%

Forward Revenue Growth

LUCD

163.5%

KRMD

17.2%

Profitability & performance

Gross Margin

KRMD

62.4%

LUCD

-21.7%

ROE

KRMD

-1063.0%

LUCD

-40434.0%

FCF Yield %

KRMD

0.2%

LUCD

-38.8%

52-Week Performance

KRMD

-29.4%

LUCD

-47.7%

Detailed metrics comparison

KRMD

KORU Medical Systems Inc

LUCD

Lucid Diagnostics Inc

Market Cap

KRMD$136M

LUCD$122M

Enterprise Value

KRMD$128M

LUCD$112M

Price

KRMD$2.96

LUCD$0.64

P/E Ratio

KRMDN/A

LUCDN/A

P/S Ratio

KRMD3.01x

LUCD22.35x

EV/Sales

KRMD2.84x

LUCD20.53x

EV/EBITDA

KRMD918.58x

LUCD0.00x

P/B Ratio

KRMD7.57x

LUCD11.67x

P/FCF Ratio

KRMD559.48x

LUCDN/A

EV/FCF

KRMD526.28x

LUCD-2.37x

PEG Ratio

KRMDN/A

LUCDN/A

Forward P/E (NTM)

KRMD1,748.17x

LUCDN/A

Forward P/S (NTM)

KRMD2.55x

LUCD13.06x

Revenue (TTM)

KRMD$45M

LUCD$5M

Revenue Growth (YoY)

KRMD22.4%

LUCD24.9%

Forward Rev Growth

KRMD17.2%

LUCD163.5%

Gross Margin (TTM)

KRMD62.4%

LUCD-21.7%

Operating Margin (TTM)

KRMD0.0%

LUCD0.0%

EBITDA Margin (TTM)

KRMD-1.9%

LUCD-914.8%

Net Margin (TTM)

KRMD-4.0%

LUCD-1193.9%

FCF Margin (TTM)

KRMD0.5%

LUCD-866.6%

Net Income (TTM)

KRMD$-2M

LUCD$-65M

FCF (TTM)

KRMD$243K

LUCD$-47M

EPS (TTM)

KRMD-$0.04

LUCD-$0.35

ROE (TTM)

KRMD-1063.0%

LUCD-40434.0%

ROA (TTM)

KRMD-651.0%

LUCD-12542.0%

ROIC (TTM)

KRMD-1045.0%

LUCD-14249.0%

Cash

KRMD$8M

LUCD$33M

Debt

KRMD$220K

LUCD$24M

Net Cash/Debt

KRMD$8M

LUCD$10M

Current Ratio (TTM)

KRMD2.72x

LUCD1.33x

Quick Ratio (TTM)

KRMD2.00x

LUCD1.29x

Debt/Equity (TTM)

KRMD0.01x

LUCD2.15x

Debt/Assets (TTM)

KRMD0.0%

LUCD0.0%

Interest Coverage (TTM)

KRMDN/A

LUCDN/A

Net Debt/EBITDA (TTM)

KRMD0.00x

LUCD0.00x

Beta

KRMD0.52

LUCD1.16

52W Performance

KRMD-29.4%

LUCD-47.7%

YTD Performance

KRMD-47.2%

LUCD-43.0%

% from 52W High

KRMD-55.2%

LUCD-60.8%

% from 52W Low

KRMD3.5%

LUCD27.6%

Asset Turnover (TTM)

KRMD1.61x

LUCD0.13x

FCF Yield (TTM)

KRMD0.2%

LUCD-38.8%

Earnings Yield (TTM)

KRMD-1.3%

LUCD-53.4%

Dividend Yield (TTM)

KRMDN/A

LUCDN/A

Rule of 40

KRMD23.0

LUCD-841.7

EV/GP/RG

KRMD0.25

LUCDN/A

Ticker research

View KRMD research View LUCD research

Metric	KRMD KORU Medical Systems Inc	LUCD Lucid Diagnostics Inc
Market & Valuation
Market Cap	$136M	$122M
Enterprise Value	$128M	$112M
Price	$2.96	$0.64
P/E Ratio	N/A	N/A
P/S Ratio	3.01x	22.35x
EV/Sales	2.84x	20.53x
EV/EBITDA	918.58x	0.00x
P/B Ratio	7.57x	11.67x
P/FCF Ratio	559.48x	N/A
EV/FCF	526.28x	-2.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1,748.17x	N/A
Forward P/S (NTM)	2.55x	13.06x
Revenue & Growth
Revenue (TTM)	$45M	$5M
Revenue Growth (YoY)	22.4%	24.9%
Forward Rev Growth	17.2%	163.5%
Profitability
Gross Margin (TTM)	62.4%	-21.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-914.8%
Net Margin (TTM)	-4.0%	-1193.9%
FCF Margin (TTM)	0.5%	-866.6%
Net Income (TTM)	$-2M	$-65M
FCF (TTM)	$243K	$-47M
EPS (TTM)	-$0.04	-$0.35
ROE (TTM)	-1063.0%	-40434.0%
ROA (TTM)	-651.0%	-12542.0%
ROIC (TTM)	-1045.0%	-14249.0%
Financial Health
Cash	$8M	$33M
Debt	$220K	$24M
Net Cash/Debt	$8M	$10M
Current Ratio (TTM)	2.72x	1.33x
Quick Ratio (TTM)	2.00x	1.29x
Debt/Equity (TTM)	0.01x	2.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.16
52W Performance	-29.4%	-47.7%
YTD Performance	-47.2%	-43.0%
% from 52W High	-55.2%	-60.8%
% from 52W Low	3.5%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	1.61x	0.13x
FCF Yield (TTM)	0.2%	-38.8%
Earnings Yield (TTM)	-1.3%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	23.0	-841.7
EV/GP/RG	0.25	N/A
Ticker research	View KRMD research	View LUCD research